[SRNE] QoQ Quarter Result on 30-Sep-2015 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
13-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- 91.43%
YoY- 87.65%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 902 988 1,337 1,103 1,173 977 798 8.51%
PBT -46,113 -20,027 -25,413 33,244 -10,975 -10,616 -10,207 173.53%
Tax -1,164 -1,637 1,186 35,323 -17 -178 1 -
NP -44,949 -18,390 -23,476 -939 -10,958 -10,438 -8,505 203.71%
Tax Rate - - - -106.25% - - - -
Total Cost 45,851 19,378 24,813 2,042 12,131 11,415 9,303 189.89%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin -4,983.26 -1,861.34 -1,755.87 -85.13 -934.19 -1,068.37 -1,065.79 179.87%
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
EPS -0.97 -0.48 -0.62 -0.03 -0.30 -0.29 -0.23 161.26%
EPS Diluted -0.97 -0.48 -0.62 -0.03 -0.30 -0.29 -0.23 161.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.